Literature DB >> 7562276

Eosinophil cationic protein in serum and nasal washes from wheezing infants and children.

J M Ingram1, G P Rakes, G E Hoover, T A Platts-Mills, P W Heymann.   

Abstract

OBJECTIVE: To compare eosinophil counts and concentrations of eosinophil cationic protein (ECP) in serum and nasal wash fluid from wheezing infants and children with those from age-matched children without respiratory tract symptoms.
DESIGN: A case-control study of 71 children treated for wheezing and 59 control subjects in the University of Virginia Pediatric Emergency Department. The patients ranged from 2 months to 16 years of age. Eosinophil numbers and ECP concentrations were assessed in serum and nasal washes. Total serum IgE was measured and the radioallergosorbent test was used to measure IgE antibody to common inhalant allergens.
RESULTS: Among children less than the age of 2 years, markedly elevated levels of ECP (> 200 ng/ml) were measured in nasal washes from 9 (41%) of 22 wheezing patients and 1 (6%) of 17 control subjects (p < 0.03). None of these children had a positive radioallergosorbent test result for IgE antibody to common aeroallergens or a nasal smear containing 10% eosinophils. Few of the wheezing children under 2 years of age had either increased concentrations of total IgE or ECP in their serum or an elevated total blood eosinophil count. After the age of 2 years, the percentage of patients with nasal ECP levels greater than 200 ng/ml was also significantly higher in wheezing children than in control subjects (p < 0.001), and a positive correlation was observed between ECP concentrations in their nasal washes and other eosinophil responses (total blood eosinophil counts, serum ECP levels, and nasal eosinophil counts).
CONCLUSION: Increased concentrations of ECP were detected in nasal washes from wheezing infants and children, indicating that eosinophils may contribute to the pathogenesis of airway inflammation in some children who wheeze early in life.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562276     DOI: 10.1016/s0022-3476(95)70112-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  5 in total

1.  Lactoferrin and eosinophilic cationic protein in nasal secretions of patients with experimental rhinovirus colds, natural colds, and presumed acute community-acquired bacterial sinusitis.

Authors:  M D Niehaus; J M Gwaltney; J O Hendley; M J Newman; P W Heymann; G P Rakes; T A Platts-Mills; R L Guerrant
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

2.  Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.

Authors:  Ann Esquivel; William W Busse; Agustin Calatroni; Alkis G Togias; Kristine G Grindle; Yury A Bochkov; Rebecca S Gruchalla; Meyer Kattan; Carolyn M Kercsmar; G Khurana Hershey; Haejin Kim; Petra Lebeau; Andrew H Liu; Stanley J Szefler; Stephen J Teach; Joseph B West; Jeremy Wildfire; Jaqueline A Pongracic; James E Gern
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405

3.  Serum eosinophilic cationic protein may predict clinical course of wheezing in young children.

Authors:  J R Villa; G García; S Rueda; A Nogales
Journal:  Arch Dis Child       Date:  1998-05       Impact factor: 3.791

4.  Predictors of severe asthma attack re-attendance in Ecuadorian children: a cohort study.

Authors:  Cristina Ardura-Garcia; Erick Arias; Paola Hurtado; Laura J Bonnett; Carlos Sandoval; Augusto Maldonado; Lisa J Workman; Thomas A E Platts-Mills; Philip J Cooper; John D Blakey
Journal:  Eur Respir J       Date:  2019-11-14       Impact factor: 16.671

Review 5.  The relevance of allergen exposure to the development of asthma in childhood.

Authors:  T A Platts-Mills; G Rakes; P W Heymann
Journal:  J Allergy Clin Immunol       Date:  2000-02       Impact factor: 10.793

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.